You are currently viewing a new version of our website. To view the old version click .

Antibiotics, Volume 11, Issue 5

May 2022 - 168 articles

Cover Story: We conducted a comparative effectiveness study of ceftolozane/tazobactam vs. aminoglycoside- or polymyxin-based therapies among hospitalized patients with positive MDR P. aeruginosa cultures. Patients treated with ceftolozane/tazobactam (n = 57) were younger (mean age of 67.5 vs. 71.1, p = 0.03) and had a higher comorbidity burden (median Charlson of 5 vs. 3, p = 0.01) as well as higher rates of spinal cord injury (38.6% vs. 21.9%, p = 0.02) and P. aeruginosa-positive bone/joint cultures (12.3% vs. 0.7%, p < 0.0001) compared with patients treated with aminoglycoside- or polymyxin-based regimens (n = 155). Inpatient mortality was significantly lower in the ceftolozane/tazobactam group compared with aminoglycosides or polymyxins (15.8% vs. 27.7%, adjusted odds ratio of 0.39, and 95% confidence interval of 0.16–0.93). View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (168)

  • Article
  • Open Access
11 Citations
4,883 Views
18 Pages

Combined PK/PD Index May Be a More Appropriate PK/PD Index for Cefoperazone/Sulbactam against Acinetobacter baumannii in Patients with Hospital-Acquired Pneumonia

  • Yingjie Zhou,
  • Jing Zhang,
  • Yuancheng Chen,
  • Jufang Wu,
  • Beining Guo,
  • Xiaojie Wu,
  • Yingyuan Zhang,
  • Minggui Wang,
  • Ru Ya and
  • Hao Huang

Cefoperazone/sulbactam (CPZ/SUL) is a β-lactam and β-lactamase inhibitor combination therapy for the treatment of respiratory tract infections. Using data from a prospective, multiple-center, open-label clinical trial in 54 patients with ho...

  • Article
  • Open Access
13 Citations
3,983 Views
14 Pages

Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program

  • Lore Thijs,
  • Charlotte Quintens,
  • Lotte Vander Elst,
  • Paul De Munter,
  • Melissa Depypere,
  • Willem-Jan Metsemakers,
  • Georges Vles,
  • Astrid Liesenborghs,
  • Jens Neefs and
  • Willy E. Peetermans
  • + 1 author

Vancomycin is commonly used in outpatient parenteral antimicrobial therapy (OPAT) of Gram-positive infections. Therapeutic drug monitoring and adverse event monitoring pose a challenge. Outcome data of vancomycin in OPAT (vOPAT) are limited. The stud...

  • Review
  • Open Access
27 Citations
13,870 Views
24 Pages

Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice

  • Laura Armengol Álvarez,
  • Greet Van de Sijpe,
  • Stefanie Desmet,
  • Willem-Jan Metsemakers,
  • Isabel Spriet,
  • Karel Allegaert and
  • Jef Rozenski

Given the increase in bacterial resistance and the decrease in the development of new antibiotics, the appropriate use of old antimicrobials has become even more compulsory. Clindamycin is a lincosamide antibiotic approved for adults and children as...

  • Article
  • Open Access
5 Citations
3,136 Views
16 Pages

The biological effects of alkaloids, curine, guattegaumerine, and verapamil, on Pseudomonas aeruginosa were investigated. These molecules did not inhibit P. aeruginosa growth but increased the sensitivity of this bacterium to carbenicillin, novobioci...

  • Article
  • Open Access
7 Citations
4,214 Views
11 Pages

The purpose of the study was to assess the antimicrobial activity of an ultraviolet-C (UVC) device against microorganisms implicated in contact lens related adverse events. An UVC device with an emitting 4.5 mm diameter Light Emitting Diode (LED; 265...

  • Article
  • Open Access
7 Citations
3,625 Views
13 Pages

Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010–2019

  • Inés Ariño Pérez,
  • Samuel J. Martínez-Domínguez,
  • Enrique Alfaro Almajano,
  • Patricia Carrera-Lasfuentes and
  • Ángel Lanas

The management and effectiveness of the treatment of Helicobacter pylori infection are heterogeneous worldwide, despite the publication of international consensus conferences and guidelines, which have been widely available for years. The aim of the...

  • Review
  • Open Access
13 Citations
5,670 Views
9 Pages

The Role of Abdominal Drain Cultures in Managing Abdominal Infections

  • Jan J. De Waele,
  • Jerina Boelens,
  • Dirk Van De Putte,
  • Diana Huis In ‘t Veld and
  • Tom Coenye

Intra-abdominal infections (IAI) are common in hospitalized patients, both in and outside of the intensive care unit. Management principles include antimicrobial therapy and source control. Typically, these infections are polymicrobial, and intra-ope...

  • Article
  • Open Access
21 Citations
4,369 Views
22 Pages

Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials

  • Noor Akbar,
  • Muhammad Kawish,
  • Naveed Ahmed Khan,
  • Muhammad Raza Shah,
  • Ahmad M. Alharbi,
  • Hasan Alfahemi and
  • Ruqaiyyah Siddiqui

To combat the public health threat posed by multiple-drug-resistant (MDR) pathogens, new drugs with novel chemistry and modes of action are needed. In this study, several drugs including Hesperidin (HES), curcumin (CUR), and Amphotericin B (AmpB) dru...

  • Article
  • Open Access
34 Citations
4,923 Views
10 Pages

An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs

  • Nour Shbaklo,
  • Silvia Corcione,
  • Costanza Vicentini,
  • Susanna Giordano,
  • Denise Fiorentino,
  • Gabriele Bianco,
  • Francesco Cattel,
  • Rossana Cavallo,
  • Carla Maria Zotti and
  • Francesco Giuseppe De Rosa

The pandemic caused by the COVID-19 virus has required major adjustments to healthcare systems, especially to infection control and antimicrobial stewardship. The objective of this study was to describe the incidence of multidrug-resistant (MDR) hosp...

  • Article
  • Open Access
10 Citations
3,854 Views
12 Pages

The Economic Impact of Carbapenem Resistant-Non Lactose Fermenter and Enterobacteriaceae Infections on Hospital Costs in Dr. Soetomo General Academic Hospital Surabaya, Indonesia

  • Yasmeen Lashari,
  • Maftuchah Rochmanti,
  • Abdul Khairul Rizki Purba,
  • Hari Basuki Notobroto,
  • Rosantia Sarassari and
  • Kuntaman Kuntaman

Background: Carbapenem resistant-non lactose fermenter (CR-NLF) and Carbapenem resistant-Enterobacteriaceae (CR-E) bacterial infections are likely to be a global threat to people’s health. However, studies on the economic impacts according to t...

of 17

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382Creative Common CC BY license